Cargando…

Real World Comparison of Rivaroxaban and Warfarin in Korean Patients with Atrial Fibrillation: Propensity Matching Cohort Analysis

Rivaroxaban has emerged as a potential alternative to warfarin for the prevention of thromboembolism in patients with atrial fibrillation (AF). However, there has been concern for the risk of major bleeding, especially in Asian patients. We investigated the efficacy and safety of rivaroxaban compare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Hyung Ki, Lee, Ki Hong, Park, Hyung Wook, Yoon, Nam Sik, Kim, Min Chul, Lee, Nuri, Kim, Ji Sung, Ahn, Youngkeun, Jeong, Myung Ho, Park, Jong Chun, Cho, Jeong Gwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chonnam National University Medical School 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351319/ https://www.ncbi.nlm.nih.gov/pubmed/30740341 http://dx.doi.org/10.4068/cmj.2019.55.1.54

Ejemplares similares

What is Standard Dose of Rivaroxaban in Elderly Asian Patients with Atrial Fibrillation: 20ms versus. 15mg?
por: Kim, Sung Soo, et al.
Publicado: (2021)

Impact of Anticoagulation Intensity in Korean Patients with Atrial Fibrillation: Is It Different from Western Population?
por: Lee, Ki Hong, et al.
Publicado: (2019)

Role of Red Cell Distribution Width in the Relationship between Clinical Outcomes and Anticoagulation Response in Patients with Atrial Fibrillation
por: Lee, Ki Hong, et al.
Publicado: (2018)

Post-operative Atrial Fibrillation Impacts on Outcomes in Transcatheter and Surgical Aortic Valve Replacement
por: Jeong, Hyung Ki, et al.
Publicado: (2021)

Standard-Intensity Versus Low-Intensity Anticoagulation with Warfarin in Asian Patients with Atrial Fibrillation: A Multi-Center, Randomized Controlled Trial
por: Cho, Jeong Gwan, et al.
Publicado: (2023)

Predictors of Progression of Tricuspid Regurgitation in Patients with Persistent Atrial Fibrillation
por: Song, Jiyeon, et al.
Publicado: (2023)

Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
por: Laliberté, François, et al.
Publicado: (2015)

Timing of heart failure development and clinical outcomes in patients with acute myocardial infarction
por: Kim, Hyung Yoon, et al.
Publicado: (2023)

Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
por: Laliberté, François, et al.
Publicado: (2015)

COVID-19 vaccination-related myocarditis: a Korean nationwide study
por: Cho, Jae Yeong, et al.
Publicado: (2023)

Transmural conduction time in an early repolarization syndrome model
por: Yoon, Namsik, et al.
Publicado: (2020)

Right Ventricular Longitudinal Conduction Delay in Patients with Brugada Syndrome
por: Yoon, Namsik, et al.
Publicado: (2021)

Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
por: Kim, Hyunmee, et al.
Publicado: (2018)

Characteristics and Clinical Outcomes of Cancer Patients Who Developed Constrictive Physiology after Pericardiocentesis
por: Park, Hyukjin, et al.
Publicado: (2021)

Predictors of Clinical Outcome in Patients with Angiographically Intermediate Lesions with Minimum Lumen Area Less than 4 mm(2) Using Intravascular Ultrasound in Non-Proximal Epicardial Coronary Artery
por: Won, Jumin, et al.
Publicado: (2018)

Association between Serum Parathyroid Hormone Levels and the Prevalence of Atrial Fibrillation: the Dong-gu Study
por: Lee, Ki Hong, et al.
Publicado: (2018)

Antiarrhythmic Effect of Artemisinin in an Ex-vivo Model of Brugada Syndrome Induced by NS5806
por: Jeong, Hyung Ki, et al.
Publicado: (2023)

A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF)
por: Kim, Hyeongsoo, et al.
Publicado: (2020)

Effect of Early Adjuvant Chemotherapy on Survival of Advanced Gastric Cancer Patients: a Propensity Score-matched Analysis
por: Lee, Yoontaek, et al.
Publicado: (2018)

Pre-discharge anemia as a predictor of adverse clinical outcomes in patients with acute decompensated heart failure
por: Kim, Min Chul, et al.
Publicado: (2019)

Atrial Fibrillation in Patients with Permanent VVI Pacemakers: Risk Factors for Atrial Fibrillation
por: Cho, Jeong Gwan, et al.
Publicado: (1997)

Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
por: Chan, Yi‐Hsin, et al.
Publicado: (2018)

Quality of Anticoagulation with Warfarin in Korean Patients with Atrial Fibrillation and Prior Stroke: A Multicenter Retrospective Observational Study
por: Hong, Keun-Sik, et al.
Publicado: (2017)

Left atrial longitudinal strain as a predictor of Cancer therapeutics-related cardiac dysfunction in patients with breast Cancer
por: Park, Hyukjin, et al.
Publicado: (2020)

Comparison of Inflammatory Mediators in Patients With Atrial Fibrillation Using Warfarin or Rivaroxaban
por: Martins, Gabriela Lopes, et al.
Publicado: (2020)

Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and Warfarin
por: Alberts, Mark, et al.
Publicado: (2020)

Effects of Age on Arterial Stiffness and Blood Pressure Variables in Patients with Newly Diagnosed Untreated Hypertension
por: Cho, Soo Kyung, et al.
Publicado: (2015)

Sex-Specific Predictors of Long-Term Mortality in Elderly Patients with Ischemic Cardiomyopathy
por: Yoon, Hyun Ju, et al.
Publicado: (2023)

Benefit of Early Statin Initiation within 48 Hours after Admission in Statin-Naïve Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Kim, Min Chul, et al.
Publicado: (2019)

Carotid artery intima-media thickness in Behcet's disease patients without significant cardiovascular involvement
por: Hong, Seo Na, et al.
Publicado: (2008)

Long-Term Clinical Outcomes of Transient and Persistent No Reflow Phenomena following Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction
por: Kim, Min Chul, et al.
Publicado: (2016)

Clinical impact of left atrial enlargement in Korean patients with atrial fibrillation
por: Cho, Min Soo, et al.
Publicado: (2021)

A prospective, observational study of rivaroxaban for stroke prevention in atrial fibrillation: the XANAP Korea
por: Shim, Jaemin, et al.
Publicado: (2021)

Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
por: Wisløff, Torbjørn, et al.
Publicado: (2014)

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Rivaroxaban equals warfarin treatment in atrial fibrillation patients at high risk of stroke
Publicado: (2010)

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
por: Breithardt, Günter, et al.
Publicado: (2016)

Current Anticoagulant Usage Patterns and Determinants in Korean Patients with Nonvalvular Atrial Fibrillation
por: Ha, Hyun Su, et al.
Publicado: (2020)

Impaired Diastolic Recovery after Acute Myocardial Infarction as a Predictor of Adverse Events
por: Yoon, Hyun Ju, et al.
Publicado: (2015)

Carotid plaque rather than intima-media thickness as a predictor of recurrent vascular events in patients with acute ischemic stroke
por: Yoon, Hyun Ju, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k7si37dvmf4f11anq6vqu4957b